Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
최신 재무제표(Form-10K)에 따르면, Fresenius SE & Co KGaA의 총 자산은 $0이며, 순이익입니다.
FSNUY의 주요 재무 비율은 무엇인가요?
Fresenius SE & Co KGaA의 유동비율은 0이고, 순이익률은 5.52, 주당 매출은 $40.53입니다.
Fresenius SE & Co KGaA의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Fresenius SE & Co KGaA 주요 수익원은 Fresenius Kabi이며, 최신 수익 발표에서 수익은 8,414,000,000입니다. 지역별로는 North America이 Fresenius SE & Co KGaA의 주요 시장이며, 수익은 2,701,000,000입니다.
Fresenius SE & Co KGaA은 수익성이 있나요?
예, 최신 재무제표에 따르면 Fresenius SE & Co KGaA의 순이익은 $1,264입니다.